國立虎尾科技大學 |

Advancing Gene Fusion Detection Towards Personalized Cancer Nanodiagnostics

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Advancing Gene Fusion Detection Towards Personalized Cancer Nanodiagnostics / by Kevin M. Koo.
作者:	Koo, Kevin M.
面頁冊數:	XIII, 102 p.online resource. :
Contained By:	Springer Nature eBook
標題:	Biomedical engineering. -
電子資源:	https://doi.org/10.1007/978-3-030-31000-4
ISBN:	9783030310004

Advancing Gene Fusion Detection Towards Personalized Cancer Nanodiagnostics
Koo, Kevin M.

Advancing Gene Fusion Detection Towards Personalized Cancer Nanodiagnostics [electronic resource] /by Kevin M. Koo. - 1st ed. 2019. - XIII, 102 p.online resource. - Springer Theses, Recognizing Outstanding Ph.D. Research,2190-5053. - Springer Theses, Recognizing Outstanding Ph.D. Research,.

Unifying Next-Generation Biomarkers and Nanodiagnostic Platforms for Precision Prostate Cancer (PCa) Management -- Colorimetric Gene Fusion Diagnostics for Visual Binary Readout -- Label –Free Surface-Enhanced Raman Scattering Detection System for Clinical Biomarker Targets -- Amplification-Free Electrochemical RNA Biomarker Sensing -- Simultaneous Analysis of Multiple Biomarkers via High-Throughput Parallel Profiling.

This book presents a unique concept of merging nanotechnology and novel urinary biomarkers for accurate early prostate cancer detection, discussing an entire progressive pipeline of innovative new strategies in biosensor development, from a simple colorimetric system to a complex system for simultaneous multiple biomarker sensing. For newcomers to the field of nucleic acid biosensing, it also describes various isothermal amplification and amplification-free strategies, which are currently the main research areas. Lastly, the book introduces and demonstrates the notion of clinical nanobiosensor validation toward clinical translation: the ultimate aim of researchers in the biosensor field. This book is a valuable reference resource learners seeking inspiration for cancer biosensor development.

ISBN: 9783030310004

Standard No.: 10.1007/978-3-030-31000-4doiSubjects--Topical Terms:

588770
Biomedical engineering.

LC Class. No.: R856-R857

Dewey Class. No.: 610.28

Advancing Gene Fusion Detection Towards Personalized Cancer Nanodiagnostics
LDR:02675nam a22004095i 4500 001 1012683
003 DE-He213
005 20200630204152.0
007 cr nn 008mamaa
008 210106s2019 gw | s |||| 0|eng d
020 $a 9783030310004 $9 978-3-030-31000-4
024 7 $a 10.1007/978-3-030-31000-4 $2 doi
035 $a 978-3-030-31000-4
050 4 $a R856-R857
072 7 $a MQW $2 bicssc
072 7 $a MED003040 $2 bisacsh
072 7 $a MQW $2 thema
082 0 4 $a 610.28 $2 23
100 1 $a Koo, Kevin M. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1306944
245 1 0 $a Advancing Gene Fusion Detection Towards Personalized Cancer Nanodiagnostics $h [electronic resource] / $c by Kevin M. Koo.
250 $a 1st ed. 2019.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a XIII, 102 p. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Springer Theses, Recognizing Outstanding Ph.D. Research, $x 2190-5053
505 0 $a Unifying Next-Generation Biomarkers and Nanodiagnostic Platforms for Precision Prostate Cancer (PCa) Management -- Colorimetric Gene Fusion Diagnostics for Visual Binary Readout -- Label –Free Surface-Enhanced Raman Scattering Detection System for Clinical Biomarker Targets -- Amplification-Free Electrochemical RNA Biomarker Sensing -- Simultaneous Analysis of Multiple Biomarkers via High-Throughput Parallel Profiling.
520 $a This book presents a unique concept of merging nanotechnology and novel urinary biomarkers for accurate early prostate cancer detection, discussing an entire progressive pipeline of innovative new strategies in biosensor development, from a simple colorimetric system to a complex system for simultaneous multiple biomarker sensing. For newcomers to the field of nucleic acid biosensing, it also describes various isothermal amplification and amplification-free strategies, which are currently the main research areas. Lastly, the book introduces and demonstrates the notion of clinical nanobiosensor validation toward clinical translation: the ultimate aim of researchers in the biosensor field. This book is a valuable reference resource learners seeking inspiration for cancer biosensor development.
650 0 $a Biomedical engineering. $3 588770
650 0 $a Nanotechnology. $3 557660
650 0 $a Cancer research. $3 1253664
650 1 4 $a Biomedical Engineering/Biotechnology. $3 1068811
650 2 4 $a Biomedical Engineering and Bioengineering. $3 1211019
650 2 4 $a Cancer Research. $3 668358
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030309992
776 0 8 $i Printed edition: $z 9783030310011
776 0 8 $i Printed edition: $z 9783030310028
830 0 $a Springer Theses, Recognizing Outstanding Ph.D. Research, $x 2190-5053 $3 1253569
856 4 0 $u https://doi.org/10.1007/978-3-030-31000-4
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)